These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4673347)

  • 1. Fertility among female survivors of the atomic bombs of Hiroshima and Nagasaki.
    Blot WJ; Sawada H
    Am J Hum Genet; 1972 Nov; 24(6 Pt 1):613-22. PubMed ID: 4673347
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of live births among survivors of Hiroshima and Nagasaki atomic bombings.
    Seigel DG
    Radiat Res; 1966 Jun; 28(2):278-88. PubMed ID: 5941154
    [No Abstract]   [Full Text] [Related]  

  • 3. STATISTICAL OBSERVATIONS OF LENTICULAR CHANGES IN SURVIVORS OF THE HIROSHIMA A-BOMB: CLINICAL AND STATISTICAL OBSERVATIONS OF DELAYED EFFECTS.
    INADA GJ; HALL CW
    Am J Ophthalmol; 1965 Feb; 59():216-21. PubMed ID: 14268794
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose estimation of human fetus exposed in utero to radiations from atomic bombs in Hiroshima and Nagasaki.
    Hashizume T; Maruyama T; Nishizawa K; Nishimura A
    J Radiat Res; 1973 Dec; 14(4):346-62. PubMed ID: 4794908
    [No Abstract]   [Full Text] [Related]  

  • 5. Reassessment of gamma doses from the atomic bombs in Hiroshima and Nagasaki.
    Maruyama T; Kumamoto Y; Noda Y
    Radiat Res; 1988 Jan; 113(1):1-14. PubMed ID: 3340713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex ratio in offspring of survivors exposed prenatally to the atomic bombs in Hiroshima and Nagasaki.
    Jablon S; Kato H
    Am J Epidemiol; 1971 Apr; 93(4):253-8. PubMed ID: 5550341
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of leukemia in atomic bomb survivors belonging to a fixed cohort in Hiroshima and Nagasaki, 1950--71. Radiation dose, years after exposure, age at exposure, and type of leukemia.
    Ichimaru M; Ishimaru T; Belsky JL
    J Radiat Res; 1978 Sep; 19(3):262-82. PubMed ID: 739446
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk of death among children of atomic bomb survivors after 62 years of follow-up: a cohort study.
    Grant EJ; Furukawa K; Sakata R; Sugiyama H; Sadakane A; Takahashi I; Utada M; Shimizu Y; Ozasa K
    Lancet Oncol; 2015 Oct; 16(13):1316-23. PubMed ID: 26384241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the radiation dose and chromosome aberrations in atomic bomb survivors of Hiroshima and Nagasaki.
    Awa AA; Sofuni T; Honda T; Itoh M; Neriishi S; Otake M
    J Radiat Res; 1978 Jun; 19(2):126-40. PubMed ID: 712662
    [No Abstract]   [Full Text] [Related]  

  • 10. [REPORT OF SURVEYS OF NAGASAKI AND HIROSHIMA ATOMIC BOMB CASUALTIES (COMPARISON OF NAGASAKI AND HIROSHIMA)].
    FUKUDA C
    Nagasaki Igakkai Zasshi; 1963 Dec; 38():SUPPL:61-4. PubMed ID: 14147511
    [No Abstract]   [Full Text] [Related]  

  • 11. Reassessment of gamma-ray doses in Hiroshima and Nagasaki.
    Maruyama T; Kumamoto Y; Noda Y
    J Radiat Res; 1991 Mar; 32 Suppl():40-7. PubMed ID: 1762130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945-1965.
    Nishiyama H; Anderson RE; Ishimaru T; Ishida K; Ii Y; Okabe N
    Cancer; 1973 Dec; 32(6):1301-9. PubMed ID: 4757920
    [No Abstract]   [Full Text] [Related]  

  • 13. Hiroshima and Nagasaki: new doses, risks, and their implications.
    Schull WJ; Shimizu Y; Kato H
    Health Phys; 1990 Jul; 59(1):69-75. PubMed ID: 2358361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mean bone marrow dose of atomic bomb survivors in Hiroshima and Nagasaki.
    Hashizume T; Maruyama T; Nishizawa K; Fukuhisa K
    J Radiat Res; 1977 Mar; 18(1):67-83. PubMed ID: 853474
    [No Abstract]   [Full Text] [Related]  

  • 15. Adult stature in relation to childhood exposure to the atomic bombs of Hiroshima and Nagasaki.
    Belsky JL; Blot WJ
    Am J Public Health; 1975 May; 65(5):489-94. PubMed ID: 1130572
    [No Abstract]   [Full Text] [Related]  

  • 16. Review of thirty years study of Hiroshima and Nagasaki atomic bomb survivors. II. Biological effects. A. Acute effects.
    Okita T
    J Radiat Res; 1975 Sep; 16 Suppl():49-66. PubMed ID: 1195203
    [No Abstract]   [Full Text] [Related]  

  • 17. Histologic review of breast cancer cases in survivors of atomic bombs in Hiroshima and Nagasaki, Japan.
    Tokuoka S; Asano M; Yamamoto T; Tokunaga M; Sakamoto G; Hartmann WH; Hutter RV; Land CE; Henson DE
    Cancer; 1984 Sep; 54(5):849-54. PubMed ID: 6331630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69.
    McGregor H; Land CE; Choi K; Tokuoka S; Liu PI; Wakabayashi T; Beebe GW
    J Natl Cancer Inst; 1977 Sep; 59(3):799-811. PubMed ID: 894745
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation therapy among atomic bomb survivors, Hiroshima and Nagasaki.
    Kato K; Antoku S; Russell WJ; Fujita S; Pinkston JA; Hayabuchi N; Hoshi M; Kodama K
    Radiat Res; 1998 Jun; 149(6):614-24. PubMed ID: 9611100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Did atomic bomb radiation influence the incidence of retinoblastoma in Nagasaki and Hiroshima?
    Amemiya T; Takano J; Choshi K
    Ophthalmic Paediatr Genet; 1993 Jun; 14(2):75-9. PubMed ID: 8233356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.